We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$97.1B
AUM Growth
+$3.73B
Cap. Flow
-$572M
Cap. Flow %
-0.59%
Top 10 Hldgs %
29.21%
Holding
7,380
New
424
Increased
3,249
Reduced
2,816
Closed
405

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$637M
2
WY icon
Weyerhaeuser
WY
+$340M
3
IQV icon
IQVIA
IQV
+$132M
4
HAL icon
Halliburton
HAL
+$123M
5
DOV icon
Dover
DOV
+$112M

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Healthcare 5.12%
3 Financials 4.53%
4 Consumer Discretionary 4.09%
5 Communication Services 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSO icon
6901
Pearson
PSO
$10.5B
-1,892
Closed -$17K
PSP icon
6902
Invesco Global Listed Private Equity ETF
PSP
$233M
$0 ﹤0.01%
3
P
6903
PUT
Everpure Inc
P
$25B
-800
Closed -$10K
RAMP icon
6904
CALL
LiveRamp
RAMP
$2.3B
-7,500
Closed -$195K
RARE icon
6905
CALL
Ultragenyx Pharmaceutical
RARE
$2.56B
-600
Closed -$37K
RCKT icon
6906
Rocket Pharmaceuticals
RCKT
$351M
$0 ﹤0.01%
1
-7,036
-100% -$32.2K
REFR icon
6907
Research Frontiers
REFR
$13.6M
$0 ﹤0.01%
61
-23
-27% -$28
RGEN icon
6908
PUT
Repligen
RGEN
$8.1B
-40,000
Closed -$1.66M
RGLS
6909
DELISTED
Regulus Therapeutics
RGLS
$0 ﹤0.01%
1
-413
-100% -$51.9K
RHI icon
6910
PUT
Robert Half
RHI
$3.81B
-100
Closed -$5K
RS icon
6911
PUT
Reliance Steel & Aluminium
RS
$20.5B
-2,400
Closed -$175K
RYZ
6912
CALL
Ryerson Holding Corp
RYZ
$1.39B
-200
Closed -$2K
SAN icon
6913
Banco Santander
SAN
$202B
$0 ﹤0.01%
1
-195,678
-100% -$1.25M
SANW
6914
DELISTED
S&W Seed Co
SANW
$0 ﹤0.01%
5
-247
-98% -$16.3K
SCM icon
6915
Stellus Capital Investment Corp
SCM
$216M
-50
Closed -$1K
SEED icon
6916
Origin Agritech
SEED
$12.1M
0
SFL icon
6917
CALL
SFL Corp
SFL
$1.64B
-11,200
Closed -$152K
SGU icon
6918
Star Group
SGU
$412M
-116
Closed -$1K
SIMO icon
6919
PUT
Silicon Motion
SIMO
$8.65B
-2,200
Closed -$106K
SLGN icon
6920
PUT
Silgan Holdings
SLGN
$4.34B
-200
Closed -$6K
DCOY
6921
Decoy Therapeutics
DCOY
$2.09M
0
SLRC icon
6922
SLR Investment Corp
SLRC
$696M
-5
Closed
SMIN icon
6923
iShares MSCI India Small-Cap ETF
SMIN
$753M
-1,133
Closed -$50K
SMSI icon
6924
Smith Micro Software
SMSI
$13.9M
0
SOHO
6925
DELISTED
Sotherly Hotels
SOHO
$0 ﹤0.01%
40

Similar funds

Barclays's Q3 2017 Portfolio in Review

As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.

  • Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
  • Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
  • Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
  • Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
  • Barclays opened 424 new positions and closed 405 in Q3 2017.
  • Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.

Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.